Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Badolato

Showing results (131-140 of 183) with videos related to

Pageof 19
Sort By:
Neuron|June 7, 2025
Neurodevelopmental origins of structural and psychomotor defects in CXCR4-linked primary immunodeficiencyGiulia Demenego, Sara Mancinelli, Antonella Borreca, et al.
Immunity, Inflammation and Disease|February 25, 2023
Reduced probability of improving viro-immunological state in subjects with vertical transmission of HIV reaching adult age: A multicenter retrospective cohort studyFrancesca Pennati, Stefano Calza, Antonio Di Biagio, et al.
Journal of Clinical Immunology|June 29, 2020
Prevalence of Immunological Defects in a Cohort of 97 Rubinstein-Taybi Syndrome PatientsFrancesco Saettini, Richard Herriot, Elisabetta Prada, et al.
Blood|March 2, 2006
Innate immunity defects in Hermansky-Pudlak type 2 syndromeStefania Fontana, Silvia Parolini, William Vermi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 25, 2009
Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?Luisa Galli, Donella Puliti, Elena Chiappini, et al.
Clinical Immunology (Orlando, Fla.)|July 19, 2020
Paediatric MAS/HLH caused by a novel monoallelic activating mutation in p110δVassilios Lougaris, Manuela Baronio, Andrea Castagna, et al.
The Pediatric Infectious Disease Journal|August 19, 2025
Pharmacokinetics, Safety, Tolerability and Antiviral Activity of Switching to Oral Rilpivirine in Combination With Other Antiretroviral Therapy in Virologically Suppressed Children Living With HIV-1 Infection: Forty-eight-week Results From the Phase 2, Open-label, Single-arm, PICTURE StudyJohan Lombaard, Francis Ssali, Visal Moolasart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2011
Risk of perinatal HIV infection in infants born in Italy to immigrant mothersElena Chiappini, Luisa Galli, Catiuscia Lisi, et al.
Molecular Therapy. Methods & Clinical Development|September 11, 2023
Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated <i>in vitro</i> and <i>in vivo</i>Claudia Asperti, Daniele Canarutto, Simona Porcellini, et al.
Acta Paediatrica (Oslo, Norway : 1992)|March 29, 2012
Antiretroviral use in Italian children with perinatal HIV infection over a 14-year periodElena Chiappini, Luisa Galli, Pier-Angelo Tovo, et al.
Pageof 19

Showing results (131-140 of 183) with videos related to

Sort By:
Pageof 19
Neuron|June 7, 2025
Neurodevelopmental origins of structural and psychomotor defects in CXCR4-linked primary immunodeficiencyGiulia Demenego, Sara Mancinelli, Antonella Borreca, et al.
Immunity, Inflammation and Disease|February 25, 2023
Reduced probability of improving viro-immunological state in subjects with vertical transmission of HIV reaching adult age: A multicenter retrospective cohort studyFrancesca Pennati, Stefano Calza, Antonio Di Biagio, et al.
Journal of Clinical Immunology|June 29, 2020
Prevalence of Immunological Defects in a Cohort of 97 Rubinstein-Taybi Syndrome PatientsFrancesco Saettini, Richard Herriot, Elisabetta Prada, et al.
Blood|March 2, 2006
Innate immunity defects in Hermansky-Pudlak type 2 syndromeStefania Fontana, Silvia Parolini, William Vermi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 25, 2009
Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?Luisa Galli, Donella Puliti, Elena Chiappini, et al.
Clinical Immunology (Orlando, Fla.)|July 19, 2020
Paediatric MAS/HLH caused by a novel monoallelic activating mutation in p110δVassilios Lougaris, Manuela Baronio, Andrea Castagna, et al.
The Pediatric Infectious Disease Journal|August 19, 2025
Pharmacokinetics, Safety, Tolerability and Antiviral Activity of Switching to Oral Rilpivirine in Combination With Other Antiretroviral Therapy in Virologically Suppressed Children Living With HIV-1 Infection: Forty-eight-week Results From the Phase 2, Open-label, Single-arm, PICTURE StudyJohan Lombaard, Francis Ssali, Visal Moolasart, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2011
Risk of perinatal HIV infection in infants born in Italy to immigrant mothersElena Chiappini, Luisa Galli, Catiuscia Lisi, et al.
Molecular Therapy. Methods & Clinical Development|September 11, 2023
Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated <i>in vitro</i> and <i>in vivo</i>Claudia Asperti, Daniele Canarutto, Simona Porcellini, et al.
Acta Paediatrica (Oslo, Norway : 1992)|March 29, 2012
Antiretroviral use in Italian children with perinatal HIV infection over a 14-year periodElena Chiappini, Luisa Galli, Pier-Angelo Tovo, et al.
Pageof 19